Cargando…
Effect of antiamyloid-β drugs on Alzheimer’s disease: study protocol for a systematic review and meta-analysis
INTRODUCTION: Alzheimer’s disease (AD) is a neurodegenerative disease with a complex aetiology involving multiple targets and pathways. With the continuous growth of the ageing population, the burden of AD is increasing year by year. However, there has not been new drug approved for over a decade. I...
Autores principales: | Lyu, Diyang, Shi, Yuqing, Lyu, Xuanxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137253/ https://www.ncbi.nlm.nih.gov/pubmed/34006557 http://dx.doi.org/10.1136/bmjopen-2020-048453 |
Ejemplares similares
-
Resting-state functional reorganisation in Alzheimer’s disease and amnestic mild cognitive impairment: protocol for a systematic review and meta-analysis
por: Lyu, Diyang, et al.
Publicado: (2021) -
Effects of different kinds of anti-Alzheimer’s disease drugs on cognitive improvement: protocol for a systematic review and network meta-analysis of phase III clinical trials
por: Lyu, Diyang, et al.
Publicado: (2022) -
Dendrimers as Antiamyloid Agents
por: Sorokina, Svetlana A., et al.
Publicado: (2022) -
Tai Chi for Stroke Rehabilitation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Lyu, Diyang, et al.
Publicado: (2018) -
Impacts of FDA approval and Medicare restriction on antiamyloid therapies for Alzheimer's disease: patient outcomes, healthcare costs, and drug development
por: Brockmann, Rouen, et al.
Publicado: (2023)